Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Nishihara

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Frontiers in Neurology|October 30, 2023
Antineutrophil cytoplasmic antibody-associated vasculitis with predominant truncal muscle weakness: a retrospective case seriesJoe Nemoto, Hideaki Nishihara, Taro Yasuhi, et al.
STAR Protocols|June 21, 2021
Differentiation of human pluripotent stem cells to brain microvascular endothelial cell-like cells suitable to study immune cell interactionsHideaki Nishihara, Benjamin D Gastfriend, Pelin Kasap, et al.
Plos One|March 17, 2015
Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosisHideaki Nishihara, Fumitaka Shimizu, Yasuteru Sano, et al.
Plos One|April 2, 2014
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrierFumitaka Shimizu, Ayako Tasaki, Yasuteru Sano, et al.
Plos One|August 9, 2014
Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypesFumitaka Shimizu, Setsu Sawai, Yasuteru Sano, et al.
Brain and Behavior|April 20, 2018
Fingolimod promotes blood-nerve barrier properties in vitroHideaki Nishihara, Toshihiko Maeda, Yasuteru Sano, et al.
Elife|November 10, 2021
Wnt signaling mediates acquisition of blood-brain barrier properties in naïve endothelium derived from human pluripotent stem cellsBenjamin D Gastfriend, Hideaki Nishihara, Scott G Canfield, et al.
Journal of Neuroinflammation|May 23, 2023
High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4<sup>+</sup> T cell arrest on the inflamed BBB under flow in vitroSasha Soldati, Alexander Bär, Mykhailo Vladymyrov, et al.
Plos One|March 27, 2015
Markedly increased IP-10 production by blood-brain barrier in neuromyelitis opticaFumitaka Shimizu, Hideaki Nishihara, Yasuteru Sano, et al.
Neurology. Genetics|August 15, 2017
Autopsy case of the <i>C12orf65</i> mutation in a patient with signs of mitochondrial dysfunctionHideaki Nishihara, Masatoshi Omoto, Masaki Takao, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Neurology|October 30, 2023
Antineutrophil cytoplasmic antibody-associated vasculitis with predominant truncal muscle weakness: a retrospective case seriesJoe Nemoto, Hideaki Nishihara, Taro Yasuhi, et al.
STAR Protocols|June 21, 2021
Differentiation of human pluripotent stem cells to brain microvascular endothelial cell-like cells suitable to study immune cell interactionsHideaki Nishihara, Benjamin D Gastfriend, Pelin Kasap, et al.
Plos One|March 17, 2015
Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosisHideaki Nishihara, Fumitaka Shimizu, Yasuteru Sano, et al.
Plos One|April 2, 2014
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrierFumitaka Shimizu, Ayako Tasaki, Yasuteru Sano, et al.
Plos One|August 9, 2014
Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypesFumitaka Shimizu, Setsu Sawai, Yasuteru Sano, et al.
Brain and Behavior|April 20, 2018
Fingolimod promotes blood-nerve barrier properties in vitroHideaki Nishihara, Toshihiko Maeda, Yasuteru Sano, et al.
Elife|November 10, 2021
Wnt signaling mediates acquisition of blood-brain barrier properties in naïve endothelium derived from human pluripotent stem cellsBenjamin D Gastfriend, Hideaki Nishihara, Scott G Canfield, et al.
Journal of Neuroinflammation|May 23, 2023
High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4<sup>+</sup> T cell arrest on the inflamed BBB under flow in vitroSasha Soldati, Alexander Bär, Mykhailo Vladymyrov, et al.
Plos One|March 27, 2015
Markedly increased IP-10 production by blood-brain barrier in neuromyelitis opticaFumitaka Shimizu, Hideaki Nishihara, Yasuteru Sano, et al.
Neurology. Genetics|August 15, 2017
Autopsy case of the <i>C12orf65</i> mutation in a patient with signs of mitochondrial dysfunctionHideaki Nishihara, Masatoshi Omoto, Masaki Takao, et al.
Pageof 4